The MarketReader Minute
đź’Š IBB Falls as Fed Holds Rates, Sector Reacts to Leadership Shakeup and Earnings Miss | Biotech Sector Insights
(IBB) declined 0.6% as markets absorbed the Fed’s steady rate stance and Q2 GDP growth of 3%. The removal of Vinay Prasad from the FDA was seen as a sector-positive move, though broader market weakness—evident in the Russell 2000’s drop—also weighed on IBB.